| Welsh, Carson, Anderson & Stowe makes strategic investment in GovernmentCIO, TPG talks WellSky 2.0 following $1.35bn bet on CarePort, Apollo has plowed ~$5bn into covid-ravaged aerospace industry this year | | Friday, October 16, 2020 | | | Happy Friday! WellSky, a post-acute-care software company, is carving out AllScript's CarePort in a $1.35 billion transaction. The deal comes a few months after Leonard Green joined TPG as an investor in WellSky, writes Sarah Pringle on PE Hub. CarePort was one of two top deals of scale TPG and WellSky identified, Sarah writes. In buying CarePort, WellSky is able to manage the discharge process from the acute-care setting into the post-acute-care setting. In other words, the new technology will give healthcare payers visibility as patients move from one care setting to the next, Nehal Raj, partner at TPG, explained. Read Sarah's story here on PE Hub. |
|
| Top Scoops | | Welsh, Carson, Anderson & Stowe made a strategic investment in GovernmentCIO, which provides technology and digital services to the federal health IT services market. Jim Brabston, former senior executive with Stanley, Inc. and Chamber Corp, joined the company as chief executive. Read more here on PE Hub. |
|
| Have a great weekend! Reach me with your thoughts, tips, gossip, whatever at cwitkowsky@buyoutsinsider.com, on Twitter or find me on LinkedIn. HOUSEKEEPING Wanted: VCJ’s Rising Stars It’s that time of the year. Over at Venture Capital Journal, editor Alastair Goldfisher and the team are looking for nominations for their second annual Rising Stars list. VCJ is seeking to identify the most talented and up-and-coming professionals in the venture capital community. Click here for more information on how you can submit your favorite Rising Star. | |
|
| | | | | | | | | | | | | | | | | | | | VectivBio reels in $110m | VectivBio AG, a Swiss developer of transformational medicines for patients with serious rare diseases, has raised $110 million in financing. More... |
| | | | | | | | | | | | | | | | | | | | | | | | Instylla lands $25.4m Series B | Bedford, Massachusetts-based Instylla Inc, a developer of minimally invasive liquid embolic products designed for use in peripheral vascular embolotherapy, has closed $25.4 million in Series B financing. More... |
| | | | | | | | WiserCare picks up $3.6m | WiserCare, a digital health platform for decision support and preference-aligned care, has raised $3.6 million in financing. More... |
| |
|
To update your PE Hub email preferences, or to unsubscribe, click here. |
| | |
|